We successfully developed PLGA‐PEG NBs targeted CAIX for detecting hypoxia regions within tumors, with small size to penetrate microvessels and arrive at the surface of cells, which was able to detect breast cancer acquired tamoxifen resistance in vitro and in vivo. Here, CA9 is linked to breast cancer.